US Stock MarketDetailed Quotes
QLGN Qualigen Therapeutics
- 0.4341
- +0.2288+111.45%
Close Jul 12 16:00 ET
- 0.3304
- -0.1037-23.89%
Post 19:59 ET
4.17MMarket Cap-194P/E (TTM)
0.5887High0.2851Low420.24MVolume0.2992Open0.2053Pre Close180.42MTurnover4383.20%Turnover RatioLossP/E (Static)9.61MShares1.260052wk High-1.19P/B4.16MFloat Cap0.144952wk Low--Dividend TTM9.59MShs Float13749.7500Historical High--Div YieldTTM147.88%Amplitude0.1449Historical Low0.4290Avg Price1Lot Size
Qualigen Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 59.65%-783.59K | 14.20%-9.09M | 7.84%-1.84M | -118.17%-1.69M | 8.25%-3.62M | 49.97%-1.94M | 28.05%-10.6M | 31.51%-2M | 74.42%-775.69K | 41.14%-3.95M |
| Net income from continuing operations | 37.16%-2.03M | 10.22%-12.48M | 31.44%-2.47M | -29.46%-2.39M | -6.11%-4.38M | 25.11%-3.24M | 22.36%-13.89M | 14.69%-3.6M | 39.16%-1.85M | 40.77%-4.13M |
| Operating gains losses | 112.11%125.74K | -64.50%-1.38M | -113.32%-24.02K | 118.44%59.26K | -2,445.22%-376.69K | -52.02%-1.04M | 81.04%-838.98K | 243.68%180.37K | 81.79%-321.3K | 96.41%-14.8K |
| Depreciation and amortization | ---- | -63.05%4.5K | 47.72%4.5K | -43.22%-239.09K | ---- | ---- | -96.40%12.17K | -96.59%3.04K | -295.01%-166.94K | 12.21%91.82K |
| Other non cash items | -71.32%461.93K | --2.55M | --222.44K | --459.68K | --254.18K | --1.61M | ---- | ---- | ---- | ---- |
| Change In working capital | 28.51%602.85K | 272.91%1.11M | -52.84%356.09K | 138.17%141.38K | 111.06%145.02K | 421.44%469.1K | -129.05%-642.87K | 150.08%755.03K | -78.59%59.36K | -119.72%-1.31M |
| -Change in receivables | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -165.83%-65.94K |
| -Change in inventory | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 156.28%110.98K |
| -Change in prepaid assets | 303.98%721.45K | -108.48%-264.74K | 49.24%375.36K | -701.80%-1.02M | 124.60%204.31K | -36.69%178.58K | -109.78%-126.99K | 13.49%251.51K | -48.58%169.99K | -16.59%-830.56K |
| -Change in payables and accrued expense | -140.83%-118.61K | 366.79%1.38M | -103.83%-19.28K | 163.14%138.34K | 309.73%966.75K | 185.61%290.52K | -136.01%-515.88K | 1,897.76%503.52K | -438,122.00%-219.11K | -230.50%-460.95K |
| -Change in other current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 40.21%-37.11K |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 64.69%-27.74K |
| Cash from discontinued investing activities | 0 | 54.29%-1.21M | -1,481.50%-3.83M | -692.31K | -2.65M | -242.35K | ||||
| Operating cash flow | 70.25%-783.59K | 22.22%-10.3M | -153.45%-5.67M | 129.22%929.74K | 25.79%-2.93M | 32.14%-2.63M | 10.07%-13.25M | 23.19%-2.24M | -4.94%-3.18M | 41.14%-3.95M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 365.92%121.5K | |||||||||
| Net PPE purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 69.56%-13.86K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | 2,394.23%4.22M | 196.33%235.4K | 37,642.93%4.23M | -139.84%-48.41K | -299.01%-198.01K | -29.99%-183.76K | -1,336.82%-244.38K | -16.49%-11.26K | 365.92%121.5K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 475K | -118.90%-550K | -103.79%-110K | -13,377.01%-440K | 0 | 0 | -65.49%2.91M | -64.37%2.9M | -97.44%3.31K | -100.00%1 |
| Net issuance payments of debt | --475K | -118.94%-550K | -103.79%-110K | ---- | ---- | --0 | 2,193.03%2.9M | --2.9M | ---- | ---- |
| Net common stock issuance | ---- | --0 | ---- | ---- | ---- | ---- | -100.01%-505 | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | ---- | --0 | --0 | --0 | ---- | ---- | -98.44%7.17K | --0 | -97.44%3.31K | -100.00%1 |
| Cash from discontinued financing activities | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| Financing cash flow | --475K | -118.90%-550K | -103.79%-110K | -13,377.01%-440K | --0 | --0 | -65.49%2.91M | -64.37%2.9M | -97.44%3.31K | -100.00%1 |
| Net cash flow | ||||||||||
| Beginning cash position | -94.29%401.8K | -59.86%7.04M | -68.69%2.07M | -86.19%1.35M | -88.73%1.53M | -59.86%7.04M | -26.85%17.54M | -46.23%6.62M | -35.98%9.75M | -37.99%13.61M |
| Current changes in cash | 89.10%-308.59K | 36.90%-6.64M | -1,416.63%-5.55M | 247.86%4.72M | 22.17%-2.98M | 27.89%-2.83M | -63.41%-10.52M | -91.93%421.24K | -9.52%-3.19M | 43.05%-3.82M |
| Effect of exchange rate changes | --0 | --0 | --0 | -287.53%-115.8K | -30.06%-44.52K | --160.32K | --22.64K | ---4.88K | --61.75K | ---34.23K |
| End cash Position | -93.92%93.22K | -87.31%401.8K | -87.31%401.8K | -68.69%2.07M | -86.19%1.35M | -88.73%1.53M | -81.95%3.17M | -81.95%3.17M | -46.23%6.62M | -35.98%9.75M |
| Free cash flow | 70.25%-783.59K | 22.22%-10.3M | -153.45%-5.67M | 137.72%1.18M | 19.83%-3.17M | 33.00%-2.63M | 10.92%-13.25M | 23.64%-2.24M | -2.52%-3.12M | 41.33%-3.96M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
